NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

I think we have a terminology problem. There are actually 2 separate steps, one is share authorization increase and the 2nd is 'shelf registration' as mentioned by you and others here. Shelf registration is what NWBO does relative to the SEC and/or exchange rules for registering share sales. What NWBO needs to get shareholder approval for is correctly called the total 'share authorization' as this is not a matter of shelf registration; shelf registration is a purely regulatory matter which doesn't require shareholder vote as long as the shares are authorized. I'm pretty sure that is the correct terminology we should use on this topic. We are now where an increase in authorization is likely to be needed unless the share price jumps significantly (e.g. with shares at $1 if we still have another 50M shares authorized we could raise $50M before needing to increase authorization. Admittedly that's a magic number which longs can only hope we might get after great TLD, which now may be too much to expect even on great TLD as we are in a vicious bear market, but that is another topic).

With the correct topic WRT proxy voting being 'share authorization' rather than 'shelf registration', I would just point out that the last time they did this they held the ASM without raising the increased authorization; subsequent to the ASM they held another proxy vote to increase the authorization. Unless I'm being confused they held the ASM and then afterward held another proxy vote limited to increasing the authorization. Hence there is clear precedent to argue that they will not put an authorization increase on the proxy for the ASM even if they plan to put that up for vote in the near future.